Bristol-Myers Squibb(BMY)Q1 2024 Introduction Bristol-Myers Squibb Company(BMY) continues to operate in one segment engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. Bristol-Myers Squibb Company’ revenues come from products in the following therapeutic classes: hematology, oncology, cardiovascular and immunology. Profitability analysis Bristol-Myers Squibb Company(BMY) reported $46.1…